1. Home
  2. NTAP vs BNTX Comparison

NTAP vs BNTX Comparison

Compare NTAP & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetApp Inc.

NTAP

NetApp Inc.

HOLD

Current Price

$98.73

Market Cap

19.7B

Sector

Technology

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$91.02

Market Cap

25.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTAP
BNTX
Founded
1992
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7B
25.5B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
NTAP
BNTX
Price
$98.73
$91.02
Analyst Decision
Hold
Strong Buy
Analyst Count
13
13
Target Price
$118.25
$134.15
AVG Volume (30 Days)
2.0M
1.1M
Earning Date
05-28-2026
01-01-0001
Dividend Yield
2.15%
N/A
EPS Growth
22.46
N/A
EPS
4.32
N/A
Revenue
$6,233,200,000.00
N/A
Revenue This Year
$6.00
N/A
Revenue Next Year
$5.23
$2.61
P/E Ratio
$22.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$71.84
$79.81
52 Week High
$126.66
$124.00

Technical Indicators

Market Signals
Indicator
NTAP
BNTX
Relative Strength Index (RSI) 45.34 35.49
Support Level $95.09 N/A
Resistance Level $102.92 $112.30
Average True Range (ATR) 3.15 3.29
MACD -0.18 -1.97
Stochastic Oscillator 31.61 34.40

Price Performance

Historical Comparison
NTAP
BNTX

About NTAP NetApp Inc.

NetApp Inc is a provider of enterprise data management and storage solutions. The company's segments include Hybrid Cloud and Public Cloud. It generates maximum revenue from the Hybrid Cloud segment. The Hybrid Cloud segment offers a portfolio of storage management and infrastructure solutions that help customers recast their traditional data centers with the power of the cloud. This portfolio is designed to operate with public clouds to unlock the potential of hybrid, multi-cloud operations. Hybrid Cloud is composed of software, hardware, and related support, as well as professional and other services. Geographically, the company generates the majority of its revenue from the United States, Canada and Latin America (Americas).

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: